+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2



Cutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2



Journal of Immunology 172(10): 5838-5842



To date, immunoreceptor tyrosine-based inhibition motifs (ITIMs) have been shown to mediate inhibitory properties. We report a novel triggering receptor expressed on myeloid cells (TREM) family member, TREM-like transcript-1 (TLT1), which differs from the activating members because its cytoplasmic tail contains two ITIMs at Y245 and Y281. A TLT1 splice variant (TLT1sp) encodes a different cytoplasmic tail lacking ITIMs. Both isoforms are expressed in resting platelet alpha-granules, which are up-regulated to the cell surface following activation. TLT1 recruited Src homology 2 domain-containing tyrosine phosphatase (SHP)-2 to the "classical" ITIM (Y281) but not the "nonclassical" ITIM (Y245). In contrast to previously characterized ITIM receptors, TLT1 enhanced, rather than inhibited, FcepsilonRI-mediated calcium signaling in rat basophilic leukemia cells, a property dependent on the SHP-2 recruiting classical Y281 ITIM. Therefore, TLT1 represents a new costimulatory ITIM immunoreceptor and is the second ITIM-bearing receptor to be identified in platelets after platelet endothelial cell adhesion molecule-1.

(PDF emailed within 0-6 h: $19.90)

Accession: 011915525

Download citation: RISBibTeXText

PMID: 15128762

DOI: 10.4049/jimmunol.172.10.5838


Related references

Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx. Glia 61(1): 37-46, 2013

Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells. Immunology Letters 68(1): 3-15, May 3, 1999

The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear. Thrombosis Research 135(1): 155-160, 2015

PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac. Blood 99(2): 694-697, 2002

Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circulation Research 114(7): 1174-1184, 2014

Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation. International Journal of Alzheimer's Disease 2010, 2010

Cutting Edge: Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: A study using CD3{zeta} immunoreceptor tyrosine-based activation motif transgenic mice. Journal of Immunology 182(7): 3955-3959, 2009

Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development. Journal of Thrombosis and Haemostasis 14(4): 645-654, 2017

The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling. Immunology Letters 72(1): 7-15, 2000

C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1. Circulation Research 104(11): 1275-1282, 2009

FcgammaRII expression on follicular dendritic cells and immunoreceptor tyrosine-based inhibition motif signaling in B cells. European Journal of Immunology 34(1): 98-107, 2004

Platelet hem-immunoreceptor tyrosine-based activation motif receptors: at least one required. Arteriosclerosis, Thrombosis, and Vascular Biology 33(5): 884-885, 2013

Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif. Molecular and Cellular Biology 17(8): 4305-4311, 1997

Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 34(8): 1615-1620, 2014

Signaling capacity of the T cell receptor is positively regulated by the binding of Lck to the N-terminal tyrosine of the CD3-e immunoreceptor tyrosine-based activation motif. Immunology Letters 73(2-3): 152, 2000